William C. Olson, VP, Research & Development at PROGENICS PHARMACEUTICALS INC (PGNX), sold 2,364 shares at $5.81 ($14K) on 2010-06-22, disclosed to the SEC on 2010-06-24.
Seasonal sale ($14k) by VP, Research & Development — this insider has traded PGNX in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| PGNX | SELL | 2007-12-05 | $76K | — | Filing → |
| PGNX | SELL | 2006-06-22 | $22K | — | Filing → |
| PGNX | SELL | 2006-05-08 | $336K | — | Filing → |